141 related articles for article (PubMed ID: 7890687)
1. The fibronectin-binding domain of transglutaminase.
Jeong JM; Murthy SN; Radek JT; Lorand L
J Biol Chem; 1995 Mar; 270(10):5654-8. PubMed ID: 7890687
[TBL] [Abstract][Full Text] [Related]
2. Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin.
Radek JT; Jeong JM; Murthy SN; Ingham KC; Lorand L
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3152-6. PubMed ID: 8097314
[TBL] [Abstract][Full Text] [Related]
3. Visualization of purified fibronectin-transglutaminase complexes.
LeMosy EK; Erickson HP; Beyer WF; Radek JT; Jeong JM; Murthy SN; Lorand L
J Biol Chem; 1992 Apr; 267(11):7880-5. PubMed ID: 1348509
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase.
Hang J; Zemskov EA; Lorand L; Belkin AM
J Biol Chem; 2005 Jun; 280(25):23675-83. PubMed ID: 15849356
[TBL] [Abstract][Full Text] [Related]
5. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition.
Akimov SS; Belkin AM
J Cell Sci; 2001 Aug; 114(Pt 16):2989-3000. PubMed ID: 11686302
[TBL] [Abstract][Full Text] [Related]
6. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
Khanna M; Chelladurai B; Gavini A; Li L; Shao M; Courtney D; Turchi JJ; Matei D; Meroueh S
Mol Cancer Ther; 2011 Apr; 10(4):626-36. PubMed ID: 21330459
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the interaction between transglutaminase 2 and fibronectin.
Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
[TBL] [Abstract][Full Text] [Related]
8. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin.
Lambert Vidmar S; Lottspeich F; Emod I; Planchenault T; Keil-Dlouha V
Eur J Biochem; 1991 Oct; 201(1):71-7. PubMed ID: 1915379
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical analyses of human plasma fibronectin-cytosolic transglutaminase interactions.
Achyuthan KE; Goodell RJ; Kennedye JR; Lee KN; Henley A; Stiefer JR; Birckbichler PJ
J Immunol Methods; 1995 Mar; 180(1):69-79. PubMed ID: 7534805
[TBL] [Abstract][Full Text] [Related]
10. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators.
Barsigian C; Stern AM; Martinez J
J Biol Chem; 1991 Nov; 266(33):22501-9. PubMed ID: 1682320
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments.
Fesus L; Metsis ML; Muszbek L; Koteliansky VE
Eur J Biochem; 1986 Jan; 154(2):371-4. PubMed ID: 2867902
[TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei.
Singh US; Erickson JW; Cerione RA
Biochemistry; 1995 Dec; 34(48):15863-71. PubMed ID: 7495818
[TBL] [Abstract][Full Text] [Related]
13. Putative nucleotide binding sites of guinea pig liver transglutaminase.
Takeuchi Y; Birckbichler PJ; Patterson MK; Lee KN
FEBS Lett; 1992 Jul; 307(2):177-80. PubMed ID: 1353729
[TBL] [Abstract][Full Text] [Related]
14. Primary structure of human plasma fibronectin. Characterization of a 31,000-dalton fragment from the COOH-terminal region containing a free sulfhydryl group and a fibrin-binding site.
Garcia-Pardo A; Pearlstein E; Frangione B
J Biol Chem; 1985 Aug; 260(18):10320-5. PubMed ID: 4019516
[TBL] [Abstract][Full Text] [Related]
15. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
[TBL] [Abstract][Full Text] [Related]
16. The modification of bovine beta-casein using transglutaminase purified from guinea pig liver.
Coussons PJ; Price NC; Kelly SM; Fothergill-Gilmore LA
Biochem Soc Trans; 1992 Feb; 20(1):48S. PubMed ID: 1353034
[No Abstract] [Full Text] [Related]
17. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of rat brain transglutaminase.
Ohashi H; Itoh Y; Birckbichler PJ; Takeuchi Y
J Biochem; 1995 Dec; 118(6):1271-8. PubMed ID: 8720146
[TBL] [Abstract][Full Text] [Related]
19. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
[TBL] [Abstract][Full Text] [Related]
20. Properties of purified lens transglutaminase and regulation of its transamidase/crosslinking activity by GTP.
Murthy SN; Velasco PT; Lorand L
Exp Eye Res; 1998 Sep; 67(3):273-81. PubMed ID: 9778408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
